The group IASON produces radiopharmaceuticals and supplies special laboratory products to the target group “nuclear medicine” and “laboratory medicine”. Innovative products with the highest quality standards convince customers from all over Europe.
In 2021 Curium has successfully completed the acquisition of the Austrian radiopharmaceuticals Company IASON, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions.
Curium is the world’s largest nuclear medicine company. They develop, manufacture and distribute world-class radiopharmaceutical products to help patients around the globe.